Table 2 Prevalence rates of herpes zoster in the prior five years among patients with head and neck cancer (HNC)s vs. controls.
From: Associations of head and neck cancers with herpes zoster in the preceding five years
Cancer site | Had prior herpes zoster | No prior herpes zoster | P value | ||
|---|---|---|---|---|---|
n, % | n, % | ||||
All head and neck cancers | 722 | 7.9 | 8469 | 92.1 | < 0.001 |
Oral cavity | 304 | 7.2 | 3895 | 92.8 | < 0.001 |
Oropharynx | 62 | 7.2 | 803 | 92.8 | < 0.001 |
Larynx | 66 | 9.6 | 620 | 90.4 | < 0.001 |
Hypopharynx | 50 | 6.2 | 759 | 93.8 | < 0.001 |
Nasopharynx | 196 | 9.1 | 1966 | 90.9 | < 0.001 |
Sinonasal cavities | 13 | 6.4 | 190 | 93.6 | 0.054 |
Salivary gland | 31 | 11.6 | 236 | 88.4 | < 0.001 |
Controls | 1,400 | 3.8 | 35,364 | 96.2 | |
